These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II). Campos RF; Guerreiro ML; Sobral Kde S; Lima Rde C; Andrade SG Rev Soc Bras Med Trop; 2005; 38(2):142-6. PubMed ID: 15821788 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological potential of new metronidazole/eugenol/dihydroeugenol hybrids against Trypanosoma cruzi in vitro and in vivo. Gonçalves-Santos E; Caldas IS; Fernandes VÂ; Franco LL; Pelozo MF; Feltrim F; Maciel JS; Machado JVC; Gonçalves RV; Novaes RD Int Immunopharmacol; 2023 Aug; 121():110416. PubMed ID: 37295025 [TBL] [Abstract][Full Text] [Related]
27. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease. Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280 [TBL] [Abstract][Full Text] [Related]
28. The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole. Ferraz ML; Gazzinelli RT; Alves RO; Urbina JA; Romanha AJ Antimicrob Agents Chemother; 2007 Apr; 51(4):1359-64. PubMed ID: 17220408 [TBL] [Abstract][Full Text] [Related]
29. Effects of dehydroepiandrosterone-sulfate (DHEA-S) and benznidazole treatments during acute infection of two different Trypanosoma cruzi strains. Santos CD; Loria RM; Oliveira LG; Kuehn CC; Toldo MP; Albuquerque S; do Prado JC Immunobiology; 2010 Dec; 215(12):980-6. PubMed ID: 20163889 [TBL] [Abstract][Full Text] [Related]
30. Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection. Freitas VLT; Novaes CTG; Sartori AMC; Carvalho NB; Silva SCVD; Nakanishi ÉS; Salvador F; Castro CN; Bezerra RC; Westphalen EVN; Oliveira CMR; Busser FD; Ho YL; Buccheri R; Bonilla C; Shikanai-Yasuda MA PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011961. PubMed ID: 38408095 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV. Zanusso Junior G; Massago M; Kian D; Toledo MJO Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891 [TBL] [Abstract][Full Text] [Related]
32. Distinct Treatment Outcomes of Antiparasitic Therapy in Albareda MC; Natale MA; De Rissio AM; Fernandez M; Serjan A; Alvarez MG; Cooley G; Shen H; Viotti R; Bua J; Castro Eiro MD; Nuñez M; Fichera LE; Lococo B; Scollo K; Tarleton RL; Laucella SA Front Immunol; 2018; 9():1958. PubMed ID: 30271399 [No Abstract] [Full Text] [Related]
33. Nonsteroidal anti-inflammatory is more effective than anti-oxidant therapy in counteracting oxidative/nitrosative stress and heart disease in T. cruzi-infected mice. Novaes RD; Santos EC; Fialho MDCQ; Gonçalves WG; Sequetto PL; Talvani A; Gonçalves RV Parasitology; 2017 Jun; 144(7):904-916. PubMed ID: 28134069 [TBL] [Abstract][Full Text] [Related]
34. Impact of diminazene aceturate on renin-angiotensin system, infectious myocarditis and skeletal myositis in mice: An in vitro and in vivo study. Souza-Silva TG; Vilas-Boas DF; Gonçalves-Santos E; Mazzeti AL; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD Life Sci; 2020 Sep; 257():118067. PubMed ID: 32652140 [TBL] [Abstract][Full Text] [Related]
35. Trypanosoma cruzi infection and benznidazole therapy independently stimulate oxidative status and structural pathological remodeling of the liver tissue in mice. Novaes RD; Santos EC; Cupertino MC; Bastos DS; Oliveira JM; Carvalho TV; Neves MM; Oliveira LL; Talvani A Parasitol Res; 2015 Aug; 114(8):2873-81. PubMed ID: 25912691 [TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo antiparasitic activity of Physalis angulata L. concentrated ethanolic extract against Trypanosoma cruzi. Meira CS; Guimarães ET; Dos Santos JA; Moreira DR; Nogueira RC; Tomassini TC; Ribeiro IM; de Souza CV; Ribeiro Dos Santos R; Soares MB Phytomedicine; 2015 Oct; 22(11):969-74. PubMed ID: 26407938 [TBL] [Abstract][Full Text] [Related]
37. Physical Exercise Promotes a Reduction in Cardiac Fibrosis in the Chronic Indeterminate Form of Experimental Chagas Disease. Pedra-Rezende Y; Barbosa JMC; Bombaça ACS; Dantas-Pereira L; Gibaldi D; Vilar-Pereira G; Dos Santos HAM; Ramos IP; Silva-Gomes NL; Moreira OC; Lannes-Vieira J; Menna-Barreto RFS Front Immunol; 2021; 12():712034. PubMed ID: 34804007 [TBL] [Abstract][Full Text] [Related]
38. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients. Pérez-Antón E; Egui A; Thomas MC; Puerta CJ; González JM; Cuéllar A; Segovia M; López MC PLoS Negl Trop Dis; 2018 May; 12(5):e0006480. PubMed ID: 29750791 [TBL] [Abstract][Full Text] [Related]
39. Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV. Gruendling AP; Massago M; Teston AP; Monteiro WM; Kaneshima EN; Araújo SM; Gomes ML; Barbosa Md; Toledo MJ Am J Trop Med Hyg; 2015 Jun; 92(6):1178-89. PubMed ID: 25940197 [TBL] [Abstract][Full Text] [Related]
40. Multiple myeloma and Chagas disease: qPCR as a marker for preemptive antiparasitic therapy: a case reports series and review. Carvalho NB; Freitas VLT; Seguro FS; Bezerra RC; Fatobene G; Nakanishi ÉYS; Visnadi H; Martinez G; Batista MV; Rocha V; Dulley FL; Costa SF; Shikanai-Yasuda MA Rev Inst Med Trop Sao Paulo; 2024; 66():e10. PubMed ID: 38324876 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]